Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/3383
Title: Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer
Other Titles: (In) Neoplasma
Authors: BATABYAL, S. K.
MAJHI, R.
BASU, P. S.
Keywords: Prostate Cancer
BPH
PSA
Lectin
Issue Date: 2009
Series/Report no.: Vol. 56;No. 1
Abstract: The present investigation was a lectin-based diagnosis of malignant prostate cancer (PC) by the interaction of phytohemagglutinin (PHA lectin) from Phaseolus vulgaris with the glycan part of serum prostate specific antigen (PSA ) of patients with prostatic disorder. This was confirmed by the interaction between PHA and purified PSA obtained from serum by electrophoretic separation and finally by HPL C chromatography. The precipitate of carbohydrate content after binding of PHA with purified PSA of PC was significantly higher than that of benign prostate hyperplasia (BPH) and/or normal serum PSA . The results suggest that there may be a striking difference in glycosylation pattern of PSA between BPH and PC. The cut off value ≥ 10 μg/ml of the carbohydrate content of PHA-PSA precipitate indicates strong suspicion for PC irrespective of total serum PSA cut off level ≥ 4.0ng/ml by conventional immunoassay method and this may be taken as a guideline in differentiating PC and BPH.
URI: 10.4149/neo_2009_01_68
http://172.16.0.4:8085/heritage/handle/123456789/3383
Appears in Collections:Biotechnology (Publications)

Files in This Item:
File Description SizeFormat 
Clinical utility of the interaction between lectin and serum prostate.pdf37.68 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.